Literature DB >> 11531898

One-year prevalence of migraine in Sweden: a population-based study in adults.

C Dahlöf1, M Linde.   

Abstract

A randomly selected sample of 1668 individuals (782 women and 886 men) aged 18-74 years was interviewed by telephone using a standardized questionnaire including the International Headache Society (IHS) criteria for migraine. The survey was performed by SIFO, the national public opinion poll agency. The results obtained demonstrate that 21% of the Swedish population had suffered from severe headaches during the past year. A majority of these headache sufferers (61%) fulfilled the IHS-criteria for migraine. The 1-year prevalence of migraine in Sweden was found to be 13.2 +/- 1.9% (16.7% among women and 9.5% among men). The prevalence of migraine in this Swedish population did not differ between the northern, middle and southern part of Sweden, or between urban and rural areas or different income groups. Only about half (49%) of the migraineurs had been diagnosed by a physician. Among the individuals who fulfilled the IHS criteria for migraine the mean attack-frequency was 1.3 per month and the mean attack-duration was 19 h. If the duration of the attack was disregarded as a strict criterion for migraine (attacks < 4 h and > 72 h were included), the prevalence increased to 17.0 +/- 1.9% without affecting the sex distribution. With this amendment, 92% of those who considered their headaches to be migraine or migraine-like in fact fulfilled the alternative criteria for migraine. However, only 76% of those who believed that they had migraine or migraine-like headaches fulfilled the strict IHS criteria for migraine. An extension of the time window from 4 to 72 h may be reasonable both from a pragmatic and from a rational clinical point of view.

Entities:  

Mesh:

Year:  2001        PMID: 11531898     DOI: 10.1046/j.1468-2982.2001.00218.x

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  29 in total

Review 1.  Almotriptan: a review of its use in migraine.

Authors:  Susan J Keam; Karen L Goa; David P Figgitt
Journal:  Drugs       Date:  2002       Impact factor: 9.546

2.  Utilisation of prescription and over-the-counter triptans: a cross-sectional study in Stockholm, Sweden.

Authors:  Pia Frisk; Sofia K Sporrong; Gunnar Ljunggren; Björn Wettermark; Mia von Euler
Journal:  Eur J Clin Pharmacol       Date:  2016-02-27       Impact factor: 2.953

3.  Is iron-deficiency anemia associated with migraine? Is there a role for anxiety and depression?

Authors:  Gülsüm Emel Pamuk; Mehmet Şerif Top; Mehmet Şevki Uyanık; Hilal Köker; Mustafa Akker; Recep Ak; Ömer Atalay Yürekli; Yahya Çelik
Journal:  Wien Klin Wochenschr       Date:  2015-04-09       Impact factor: 1.704

4.  Treatment of migraine and tension-type headache in Croatia.

Authors:  Vlasta Vuković; Davor Plavec; Arijana Lovrencić Huzjan; Mislav Budisić; Vida Demarin
Journal:  J Headache Pain       Date:  2010-03-06       Impact factor: 7.277

5.  Has the prevalence of migraine and tension-type headache changed over a 12-year period? A Danish population survey.

Authors:  Ann Christine Lyngberg; Birthe K Rasmussen; Torben Jørgensen; Rigmor Jensen
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

6.  Population-based study of migraine in Spanish adults: relation to socio-demographic factors, lifestyle and co-morbidity with other conditions.

Authors:  César Fernández-de-Las-Peñas; Valentín Hernández-Barrera; Pilar Carrasco-Garrido; Cristina Alonso-Blanco; Domingo Palacios-Ceña; Silvia Jiménez-Sánchez; Rodrigo Jiménez-García
Journal:  J Headache Pain       Date:  2009-12-10       Impact factor: 7.277

Review 7.  Prevalence of headache in Europe: a review for the Eurolight project.

Authors:  Lars Jacob Stovner; Colette Andree
Journal:  J Headache Pain       Date:  2010-05-16       Impact factor: 7.277

8.  Topiramate in migraine prophylaxis--results from a placebo-controlled trial with propranolol as an active control.

Authors:  Hans-Christoph Diener; Peer Tfelt-Hansen; Carl Dahlöf; Miguel J A Láinez; Giorgio Sandrini; Shuu-Jiun Wang; Walter Neto; Ujjwalla Vijapurkar; Aiden Doyle; David Jacobs
Journal:  J Neurol       Date:  2004-08       Impact factor: 4.849

9.  A cross-sectional population-based survey of migraine and headache in 21,177 Norwegians: the Akershus sleep apnea project.

Authors:  Michael Bjørn Russell; Håvard Anton Kristiansen; Jūrate Saltyte-Benth; Kari Jorunn Kvaerner
Journal:  J Headache Pain       Date:  2008-10-11       Impact factor: 7.277

Review 10.  Rizatriptan: an update of its use in the management of migraine.

Authors:  Keri Wellington; Greg L Plosker
Journal:  Drugs       Date:  2002       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.